|
1
|
Petriceks AH and Salmi D: Educational
case: Primary osteosarcoma. Acad Pathol. 6:23742895188203372019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pu F, Chen F, Chen S, Wang B, Liu J and
Shao Z: Association between GSTP1 polymorphisms and prognosis of
osteosarcoma in patients treated with chemotherapy: A
meta-analysis. Onco Targets Ther. 8:1835–1842. 2015.PubMed/NCBI
|
|
3
|
Van de Luijtgaarden AC, Kapusta L,
Bellersen L, Bokkerink JP, Kaal SE, Versleijen-Jonkers YM,
Schreuder HW and van der Graaf WT: High prevalence of late adverse
events in malignant bone tumour survivors diagnosed at adult age.
Neth J Med. 72:516–522. 2014.PubMed/NCBI
|
|
4
|
Whelan J, McTiernan A, Cooper N, Wong YK,
Francis M, Vernon S and Strauss SJ: Incidence and survival of
malignant bone sarcomas in England 1979–2007. Int J Cancer.
131:E508–E517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Castillo-Tandazo W, Mutsaers AJ and
Walkley CR: Osteosarcoma in the post genome Era: Preclinical models
and approaches to identify tractable therapeutic targets. Curr
Osteoporos Rep. 17:343–352. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moore DD and Luu HH: Osteosarcoma. Cancer
Treat Res. 162:65–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng J, Zhou Y, Li Y, Xu DP, Li S and Li
HB: Spices for prevention and treatment of cancers. Nutrients.
8:E4952016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parthasarathy N, Selwyn MA and Udayakumar
M: Tropical dry evergreen forests of 627 peninsular India: Ecology
and conservation significance. Trop Conservation Sci. 1:89–110.
2008. View Article : Google Scholar
|
|
9
|
Mehmood MH and Gilani AH: Pharmacological
basis for the medicinal use of black pepper and piperine in
gastrointestinal disorders. J Med Food. 13:1086–1096. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Chen M, Wang X, Wang Y, Duan C, Gao
G, Lu L, Wu X, Wang X and Yang H: Piperine induces autophagy by
enhancing protein phosphotase 2A activity in a rotenone-induced
Parkinson's disease model. Oncotarget. 7:60823–60843.
2016.PubMed/NCBI
|
|
11
|
Aumeeruddy MZ and Mahomoodally MF:
Combating breast cancer using combination therapy with 3
phytochemicals: Piperine, sulforaphane, and thymoquinone. Cancer.
125:1600–1611. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin Y, Xu J, Liao H, Li L and Pan L:
Piperine induces apoptosis of lung cancer a549 cells via
p53-dependent mitochondrial signaling pathway. Tumour Biol.
35:3305–3310. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhardwaj RK, Glaeser H, Becquemont L,
Klotz U, Gupta SK and Fromm MF: Piperine, a major constituent of
black pepper, inhibits human p-glycoprotein and cyp3a4. J Pharmacol
Exp Ther. 302:645–650. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sunila ES and Kuttan G: Immunomodulatory
and antitumor activity of piper longum linn and piperine. J
Ethnopharmacol. 90:339–346. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Greenshields AL, Doucette CD, Sutton KM,
Madera L, Annan H, Yaffe PB, Knickle AF, Dong Z and Hoskin DW:
Piperine inhibits the growth and motility of triple-negative breast
cancer cells. Cancer Lett. 357:129–140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gunasekaran V, Elangovan K and Niranjali
Devaraj S: Targeting hepatocellular carcinoma with piperine by
radical-mediated mitochondrial pathway of apoptosis: An in vitro
and in vivo study. Food Chem Toxicol. 105:106–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hwang YP, Yun HJ, Kim HG, Han EH, Choi JH,
Chung YC and Jeong HG: Suppression of
phorbol-12-myristate-13-acetate-induced tumor cell invasion by
piperine via the inhibition of PKCα/ERK1/2-dependent matrix
metalloproteinase-9 expression. Toxicol Lett. 203:9–19. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pathak N and Khandelwal S: Cytoprotective
and immunomodulating properties of piperine on murine splenocytes:
An in vitro study. Eur J Pharmacol. 576:160–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Taqvi SI, Shah AJ and Gilani AH: Blood
pressure lowering and vasomodulator effects of piperine. J
Cardiovasc Pharmacol. 52:452–458. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wattanathorn J, Chonpathompikunlert P,
Muchimapura S, Priprem A and Tankamnerdthai O: Piperine, the
potential functional food for mood and cognitive disorders. Food
Chem Toxicol. 46:3106–3110. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Zhu X, Li H, Li B, Sun L, Xie T,
Zhu T, Zhou H and Ye Z: Piperine inhibits proliferation of human
osteosarcoma cells via G2/M phase arrest and metastasis by
suppressing MMP-2/-9 expression. Int Immunopharmacol. 24:50–58.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan H, Xu LH, Huang MY, Zha QB, Zhao GX,
Hou XF, Shi ZJ, Lin QR, Ouyang DY and He XH: Piperine metabolically
regulates peritoneal resident macrophages to potentiate their
functions against bacterial infection. Oncotarget. 6:32468–32483.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oudin MJ and Weaver VM: Physical and
chemical gradients in the tumor microenvironment regulate tumor
cell invasion, migration, and metastasis. Cold Spring Harb Symp
Quant Biol. 81:189–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li H, Zhang K, Liu LH, Ouyang Y, Bu J, Guo
HB and Xiao T: A systematic review of matrix metalloproteinase 9 as
a biomarker of survival in patients with osteosarcoma. Tumour Biol.
35:5487–5491. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fromigue O, Hamidouche Z and Marie PJ:
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces
osteosarcoma cell invasion. J Biol Chem. 283:30549–30556. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ling L, Nurcombe V and Cool SM: Wnt
signaling controls the fate of mesenchymal stem cells. Gene.
433:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peng N, Gao S, Guo X, Wang G, Cheng C, Li
M and Liu K: Silencing of VEGF inhibits human osteosarcoma
angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT
signaling pathway. Am J Transl Res. 8:1005–1015. 2016.PubMed/NCBI
|
|
28
|
Manzano-Moreno FJ, Costela-Ruiz VJ,
Melguizo-Rodríguez L, Illescas-Montes R, García-Martínez O, Ruiz C
and Ramos-Torrecillas J: Inhibition of VEGF gene expression in
osteoblast cells by different NSAIDs. Arch Oral Biol. 92:75–78.
2008. View Article : Google Scholar
|
|
29
|
Olivares-Navarrete R, Hyzy S, Wieland M,
Boyan BD and Schwartz Z: The roles of Wnt signaling modulators
Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state
in osteogenesis on microstructured titanium surfaces. Biomaterials.
31:2015–2024. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tian J, He H and Lei G: Wnt/β-catenin
pathway in bone cancers. Tumour Biol. 35:9439–9445. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brafman D and Willert K: Wnt/β-catenin
signaling during early vertebrate neural development. Dev
Neurobiol. 77:1239–1259. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Di Fiore R, Guercio A, Puleio R, Di Marco
P, Drago-Ferrante R, D'Anneo A, De Blasio A, Carlisi D, Di Bella S,
Pentimalli F, et al: Modeling human osteosarcoma in mice through
3AB-OS cancer stem cell xenografts. J Cell Biochem. 113:3380–3392.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Katoh M and Katoh M: Molecular genetics
and targeted therapy of WNT-related human diseases (Review). Int J
Mol Med. 40:587–606. 2017.PubMed/NCBI
|
|
34
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ng TL, Gown AM, Barry TS, Cheang MC, Chan
AK, Turbin DA, Hsu FD, West RB and Nielsen TO: Nuclear beta-catenin
in mesenchymal tumors. Mod Pathol. 18:68–74. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ghosh N, Hossain U, Mandal A and Sil PC:
The wnt signaling pathway: A potential therapeutic target against
cancer. Ann N Y Acad Sci. 1443:54–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang X, Qu P, Zhao H, Zhao T and Cao N:
Cox 2 promotes epithelial-mesenchymal transition and migration in
osteosarcoma MG 63 cells via PI3K/AKT/NF kB signaling. Mol Med Rep.
20:3811–3819. 2019.PubMed/NCBI
|
|
38
|
Liu G, Yuan D, Sun P, Liu W, Wu PF, Liu H
and Yu GY: Linc00968 functions as an oncogene in osteosarcoma by
activating the PI3K/AKT/mTOR signaling. J Cell Physiol.
233:8639–8647. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang J, Yu XH, Yan YG, Wang C and Wang
WJ: PI3K/Akt signaling in osteosarcoma. Clin Chim Acta.
444:182–192. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Graziano AC, Cardile V, Avola R, Vicario
N, Parenti C, Salvatorelli L, Magro G and Parenti R: Wilms' tumor
gene 1 silencing inhibits proliferation of human osteosarcoma MG-63
cell line by cell cycle arrest and apoptosis activation.
Oncotarget. 8:13917–13931. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Perry JA, Kiezun A, Tonzi P, Van Allen EM,
Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS,
et al: Complementary genomic approaches highlight the PI3K/mTOR
pathway as a common vulnerability in osteosarcoma. Proc Natl Acad
Sci USA. 111:E5564–E5573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yoo ES, Choo GS, Kim SH, Woo JS, Kim HJ,
Park YS, Kim BS, Kim SK, Park BK, Cho SD, et al: Antitumor and
apoptosis-inducing effects of piperine on human melanoma cells.
Anticancer Res. 39:1883–1892. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lai LH, Fu QH, Liu Y, Jiang K, Guo QM,
Chen QY, Yan B, Wang QQ and Shen JG: Piperine suppresses tumor
growth and metastasis in vitro and in vivo in a 4T1 murine breast
cancer model. Acta Pharmacol Sin. 33:523–530. 2012. View Article : Google Scholar : PubMed/NCBI
|
